ZLAB compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name

ZLABZai Lab Ltd

Mkt capRevenueRevenue

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ZLABZai Lab Ltd

IPSCCentury Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ZLAB

Reportimpliedrealized× implied

Q2 FY26—▲+13.66%—

May 7 '26—▼−5.93%—

Q1 FY26—▲+1.55%—

Nov 6 '25—▼−6.65%—

IPSC1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.8%▼−4.85%×0.16

= impliedZLAB realized, solidIPSC realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

ZLABZai Lab Ltd

22.09▼−1.21%· post 22.10

Mkt cap$2.5BRevenue$106MQ2 FY26Revenue$460MFY25

IPSCCentury Therapeutics, Inc.

1.49▲+1.76%· post 1.48

ClosedOct 30 '26

Mkt cap$266.2MRevenue$109MQ1 FY25Revenue$7MFY24

Compare

ClosedOct 30 '26

ZLABZai Lab Ltd

IPSCCentury Therapeutics, Inc.

22.09▼−1.21%post 22.10

Price

1.49▲+1.76%post 1.48

$2.5B

Mkt cap

$266.2M

Q2 FY26$106M

Revenue

$109MQ1 FY25

FY25$460M

Revenue

$7MFY24

ZLAB22.09▼−1.21%vsIPSC1.49▲+1.76%ClosedOct 30 '26